Event JSON
{
"id": "bf0a731290a697e6e288761aeb1edc6d5940e4717631c7320e131329910cb77c",
"pubkey": "5d85e4ca55f98ef7920f93272d9305c4e946ed4e575c0fbb8cb75d62d8f457c1",
"created_at": 1727779236,
"kind": 1,
"tags": [
[
"proxy",
"https://med-mastodon.com/@CastlTrAstonDrs/113231740050261608",
"web"
],
[
"t",
"imastodon"
],
[
"t",
"covid19"
],
[
"imeta",
"url https://cdn.masto.host/medmastodoncom/media_attachments/files/113/231/739/154/505/894/original/9fe13005dc2ae5af.jpeg",
"m image/jpeg"
],
[
"t",
"immunology"
],
[
"t",
"publichealth"
],
[
"t",
"viralimmunology"
],
[
"t",
"sarscov2"
],
[
"proxy",
"https://med-mastodon.com/users/CastlTrAstonDrs/statuses/113231740050261608",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://med-mastodon.com/users/CastlTrAstonDrs/statuses/113231740050261608",
"pink.momostr"
],
[
"-"
]
],
"content": "#IMastodon #Immunology #Viralimmunology #Publichealth In vaccine-naive, #SARSCoV2 -positive adolescents, 1-dose mRNA-1273.222 was effective against #COVID19 based on successful immunobridging to 2-dose mRNA-1273 primary series in young adults. The findings support a simplified single-dose vaccination schedule with variant-containing mRNA vaccines, regardless of previous vaccination status. @TheLancetInfDis \n\nhttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2824%2900501-2/fulltext\nhttps://cdn.masto.host/medmastodoncom/media_attachments/files/113/231/739/154/505/894/original/9fe13005dc2ae5af.jpeg\n",
"sig": "907e1b96ec99fad4af04968282fae502cdc888a947adc649837f2f86355763a7d8f97d15810014d10586a4a6367867d552c9dd5fa4010d35bdc2da3c6d0c07da"
}
